Amphastar製藥 AMPH 深 滬
已收盤 10-10 16:00:00 美东时间
23.63
-1.340
-5.37%
華盛通- 最 高25.0235
- 今 開25.01
- 成交量 60.74万股
- 最 低 23.195
- 昨 收 24.97
- 總市值 11.14亿
- 52周最高 53.955
- 市盈率 靜 7.71
- 換手率 1.29%
- 52周最低 20.385
- 委 比 32.52%
- 總股本 4713.91万
- 歷史最高 67.66
- 量 比 1.84
- 振 幅 7.32%
- 歷史最低 6.67
- 每 手 1
- 風險率 8.78%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs
The Trump administration backs off plans to impose tariffs on generic drugs after internal debate over price impacts and supply concerns.
10-09 21:31
Amphastar Signs $2.8M Research Agreement with Hanxin
Amphastar Pharmaceuticals ( ($AMPH) ) just unveiled an update. On September 15,...
09-19 05:19
On Sept 15, Amphastar Pharmaceuticals Enters Contract Research Agreement With Hanxin
-SEC Filing
09-19 04:52
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution
Amneal Pharmaceuticals近日宣布其Sodium oxybate口服溶液500 mg/mL仿制药获得美国FDA批准，该药参考Jazz Pharmaceuticals的Xyrem，用于治疗7岁及以上narcolepsy患者的cataplexy或过度日间嗜睡。这是FDA批准的首个Sodium oxybate仿制药，将扩大Amneal平价药品系列，并提升患者获得治疗的机会。Sodium oxybate作为narcolepsy的标准治疗药物，可改善夜间睡眠并显著减少cataplexy发作。Amneal此举将为患者、医疗提供者和支付方提供更实惠的选择。
09-11 12:00
B of A Securities Maintains Neutral on Amphastar Pharma, Raises Price Target to $32
B of A Securities analyst Jason Gerberry maintains Amphastar Pharma (NASDAQ:AMPH) with a Neutral and raises the price target from $28 to $32.
08-26 23:23
Amphastar boosts pipeline with exclusive licensing deal from Nanjing Anji
Amphastar Pharmaceuticals (NASDAQ:AMPH) has entered into an exclusive license agreement with Nanjing Anji Biotechnology for the development, manufacturing, use, and commercialization of three propriet...
08-12 19:39
Piper Sandler Maintains Neutral on Amphastar Pharma, Lowers Price Target to $25
Piper Sandler analyst David Amsellem maintains Amphastar Pharma (NASDAQ:AMPH) with a Neutral and lowers the price target from $30 to $25.
08-08 19:25
Amphastar Pharma Q2 Adj. EPS $0.85 Beats $0.76 Estimate, Sales $174.414M Beat $174.249M Estimate
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.76 by 11.99 percent. This is a 9.57 percent decrease over earnings of $0.94 per share from the
08-08 04:09
快讯 | Amphastar Pharmaceuticals 第二季度每股收益 0.64 美元
Amphastar Pharmaceuticals Q2 EPS USD 0.64
08-08 04:05
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
